Skip to Main Content

Author Details

Jinbo Yang
School of Medicine and Pharmacy, Ocean University of China
2003
55
21
PMIDPaper TitleJournal TitlePublished Year
36596875Type I interferon signaling facilitates resolution of acute liver injury by priming macrophage polarization.Cell Mol Immunol2023
36717564Mechanism of regulation of the Helicobacter pylori Cagβ ATPase by CagZ.Nat Commun2023
36758305Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist.Eur J Med Chem2023
35963848Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).Signal Transduct Target Ther2022
35799071Transmissible ER stress between macrophages and tumor cells configures tumor microenvironment.Cell Mol Life Sci2022
32759968A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses.Cell Res2021
33827893Regulation of Anion Channel LRRC8 Volume-Regulated Anion Channels in Transport of 2'3'-Cyclic GMP-AMP and Cisplatin under Steady State and Inflammation.J Immunol2021
33597177TSC1 Suppresses Macrophage Necroptosis for the Control of Infection by Fungal Pathogen <i>Candida albicans</i>.Immunohorizons2021
33779055Natural Triterpenoids Isolated from Akebia trifoliata Stem Explants Exert a Hypoglycemic Effect via α-Glucosidase Inhibition and Glucose Uptake Stimulation in Insulin-Resistant HepG2 Cells.Chem Biodivers2021
34830015Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease.Int J Mol Sci2021
30852741Overexpression of Pyruvate Kinase M2 in Tumor Tissues Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.Pathol Oncol Res2020
31802375Combination of a novel microtubule inhibitor MBRI-001 and gemcitabine synergistically induces cell apoptosis by increasing DNA damage in pancreatic cancer cell lines.Invest New Drugs2020
32829850Sulfated polymannuroguluronate TGC161 ameliorates leukopenia by inhibiting CD4<sup>+</sup> T cell apoptosis.Carbohydr Polym2020
32682051Inhibition of IRAK4 kinase activity improves ethanol-induced liver injury in mice.J Hepatol2020
32532922Loss of ZIP facilitates JAK2-STAT3 activation in tamoxifen-resistant breast cancer.Proc Natl Acad Sci U S A2020
31612426Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3.Invest New Drugs2020
31087223Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signaling.Invest New Drugs2020
30726872E2F is required for STAT3-mediated upregulation of cyclin B1 and Cdc2 expressions and contributes to G2-M phase transition.Acta Biochim Biophys Sin (Shanghai)2019
31725079Chrysin Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Reducing Intracellular Calcium Concentration in Pulmonary Arterial Smooth Muscle Cells.J Cardiovasc Pharmacol2019
31359244TGF-β2 antagonizes IL-6-promoted cell survival.Mol Cell Biochem2019
31433805TSC1/mTOR-controlled metabolic-epigenetic cross talk underpins DC control of CD8+ T-cell homeostasis.PLoS Biol2019
31320068A β-1,3/1,6-glucan from Durvillaea Antarctica inhibits tumor progression in vivo as an immune stimulator.Carbohydr Polym2019
31035725The Inhibitory Effect of Propylene Glycol Alginate Sodium Sulfate on Fibroblast Growth Factor 2-Mediated Angiogenesis and Invasion in Murine Melanoma B16-F10 Cells In Vitro.Mar Drugs2019
30732758Structure-activity relationship of propylene glycol alginate sodium sulfate derivatives for blockade of selectins binding to tumor cells.Carbohydr Polym2019
29138867Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model.Oncol Rep2018
29422966Inhibition of breast cancer cell survival by Xanthohumol via modulation of the Notch signaling pathway <i>in vivo</i> and <i>in vitro</i>.Oncol Lett2018
29581268IRF9 and unphosphorylated STAT2 cooperate with NF-κB to drive IL6 expression.Proc Natl Acad Sci U S A2018
27852626Negative regulation of type I IFN signaling by phosphorylation of STAT2 on T387.EMBO J2017
28260066Repression of the expression of TET2 by ZEB1 contributes to invasion and growth in glioma cells.Mol Med Rep2017
27793668ZIP restores estrogen receptor expression and response to Tamoxifen in estrogen receptor negative tumors.Biochem Biophys Res Commun2016
25583084Dehydrocrenatidine is a novel janus kinase inhibitor.Mol Pharmacol2015
24401319TPCA-1 is a direct dual inhibitor of STAT3 and NF-κB and regresses mutant EGFR-associated human non-small cell lung cancers.Mol Cancer Ther2014
25217633Critical role for lysine 685 in gene expression mediated by transcription factor unphosphorylated STAT3.J Biol Chem2014
25107644N6-substituted adenosine analogues, a novel class of JAK2 inhibitors, potently block STAT3 signaling in human cancer cells.Cancer Lett2014
24735734Activation of Akt protects cancer cells from growth inhibition induced by PKM2 knockdown.Cell Biosci2014
23704931Brevilin A, a novel natural product, inhibits janus kinase activity and blocks STAT3 signaling in cancer cells.PLoS One2013
24082147STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor.Proc Natl Acad Sci U S A2013
23593410PMS1077 sensitizes TNF-α induced apoptosis in human prostate cancer cells by blocking NF-κB signaling pathway.PLoS One2013
22581330STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6/STAT3 signalling pathway.J Biosci2012
22753228Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.Neuro Oncol2012
22621920ATP depletion triggers acute myeloid leukemia differentiation through an ATR/Chk1 protein-dependent and p53 protein-independent pathway.J Biol Chem2012
21166594The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins.J Interferon Cytokine Res2011
21625555Modeling a new water channel that allows SET9 to dimethylate p53.PLoS One2011
21481791Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3.Cancer Cell2011
20812915PMS-1077, a PAF antagonist, induced differentiation of HL-60 cells with its novel activity.Cell Biol Int2010
21317457Sumoylation of vimentin354 is associated with PIAS3 inhibition of glioma cell migration.Oncotarget2010
21098664Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes.Proc Natl Acad Sci U S A2010
17993285Seleno-podophyllotoxin derivatives induce hepatoma SMMC-7721 cell apoptosis through Bax pathway.Cell Biol Int2008
19179760Redifferentiation of human hepatoma cells (SMMC-7721) induced by two new highly oxygenated bisabolane-type sesquiterpenes.J Biosci2008
18675342WITHDRAWN: SOCS3 mediates IL-1beta-dependent inhibition of IL-6-induced gene expression.Cell Signal2008
  • 1 - 50 of 55

Recommended Authors

Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Seoul National University, College of Medicine
Career Start Year 2010
Number of shared co-authors 1
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
The Second Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 2007
Number of shared co-authors 1
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 1
Shanghai General Hospital, Shanghai Jiaotong University
Career Start Year 2007
Number of shared co-authors 0
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Jilin University
Career Start Year 2005
Number of shared co-authors 0
National Institute of Arthritis
Career Start Year 2005
Number of shared co-authors 0
The First Affiliated Hospital of Guangdong Pharmaceutical University
Career Start Year 2005
Number of shared co-authors 0
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 0
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 3
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
the Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Career Start Year 2000
Number of shared co-authors 1
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 0
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 1
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Obstetrics and Gynecology Hospital of Fudan University
Career Start Year 1997
Number of shared co-authors 0
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
Career Start Year 1995
Number of shared co-authors 1
The Institute of Biomedical Sciences, East China Normal University
Career Start Year 1994
Number of shared co-authors 0
University of California, Los Angeles (university of california los angeles)
Career Start Year 1991
Number of shared co-authors 1
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 1
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 2
University of Vienna
Career Start Year 1985
Number of shared co-authors 1
University of California San Francisco
Career Start Year 1985
Number of shared co-authors 0

Collaborators

MirX Pharmaceuticals
Co-authored papers 4
Shandong Jianzhu University
Co-authored papers 3
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Lerner Research Institute, Cleveland Clinic
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Co-authored papers 1
Xuanwu Hospital, Capital Medical University
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
MD Anderson Cancer Center
Co-authored papers 1
Washington University School of Medicine
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
NYU Grossman School of Medicine
Co-authored papers 1
Case Western Reserve University
Co-authored papers 1
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
South China University of Technology
Co-authored papers 1
Baylor College of Medicine, The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Case Western Reserve University
Co-authored papers 1